Rebecca Krochmal1, Chakravarthy Reddy2, Lonny Yarmus3, Neeraj R Desai4, David Feller-Kopman3, Hans J Lee3. 1. Division of Pulmonary and Critical Care Medicine, University of Maryland Medical Center, Baltimore, USA. 2. Division of Pulmonary and Critical Care Medicine, University of Utah Health Sciences Center, Salt Lake City, USA. 3. Section of Interventional Pulmonology, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, USA. 4. Chicago Chest Center, Elk Grove Village, USA.
Abstract
BACKGROUND: Malignant pleural effusions (MPEs) represent advanced stage disease with potentially significant patient discomfort due to dyspnea. Palliative management options include repetitive thoracenteses, placement of a tunneled pleural catheter (TPC), chemical pleurodesis, or some combination of these procedures. The rapid pleurodesis procedure combines thoracoscopic talc pleurodesis and insertion of a TPC at the same time with the goals of reducing both the length of hospitalization and the duration of catheter use. The rapid pleurodesis procedure has previously been described to achieve both of these goals in a pilot study of 30 patients with fully expandable lungs. Both symptoms of dyspnea and quality of life improved with few complications. Additional data on procedural effectiveness is needed to optimize patient selection for this procedure. METHODS: We performed a retrospective analysis of patients who had undergone rapid pleurodesis protocol at two academic institutions over a 40-month period. Data was collected and analyzed on time to removal of the TPC, chemotherapy, malignancy type, complications, age, and catheter occlusion. RESULTS: A total of 29 patients underwent the rapid pleurodesis protocol with a median hospital length of stay of 2 days. Total length of hospitalization was not significantly different between patients with and without primary lung cancer. Median duration of the indwelling TPC was 10 days. Patients with primary lung cancer and those actively or recently undergoing chemotherapy maintained the catheter longer than their counterparts. CONCLUSIONS: The rapid pleurodesis protocol should be considered a viable treatment option for select patients with symptomatic recurrent MPEs undergoing chemical pleurodesis.
BACKGROUND:Malignant pleural effusions (MPEs) represent advanced stage disease with potentially significant patient discomfort due to dyspnea. Palliative management options include repetitive thoracenteses, placement of a tunneled pleural catheter (TPC), chemical pleurodesis, or some combination of these procedures. The rapid pleurodesis procedure combines thoracoscopic talc pleurodesis and insertion of a TPC at the same time with the goals of reducing both the length of hospitalization and the duration of catheter use. The rapid pleurodesis procedure has previously been described to achieve both of these goals in a pilot study of 30 patients with fully expandable lungs. Both symptoms of dyspnea and quality of life improved with few complications. Additional data on procedural effectiveness is needed to optimize patient selection for this procedure. METHODS: We performed a retrospective analysis of patients who had undergone rapid pleurodesis protocol at two academic institutions over a 40-month period. Data was collected and analyzed on time to removal of the TPC, chemotherapy, malignancy type, complications, age, and catheter occlusion. RESULTS: A total of 29 patients underwent the rapid pleurodesis protocol with a median hospital length of stay of 2 days. Total length of hospitalization was not significantly different between patients with and without primary lung cancer. Median duration of the indwelling TPC was 10 days. Patients with primary lung cancer and those actively or recently undergoing chemotherapy maintained the catheter longer than their counterparts. CONCLUSIONS: The rapid pleurodesis protocol should be considered a viable treatment option for select patients with symptomatic recurrent MPEs undergoing chemical pleurodesis.
Authors: Christopher R Gilbert; Hans J Lee; Joseph H Skalski; Fabien Maldonado; Momen Wahidi; Philip J Choi; Jamie Bessich; Daniel Sterman; A Christine Argento; Samira Shojaee; Jed A Gorden; Candice L Wilshire; David Feller-Kopman; Ricardo Ortiz; Bareng Aletta Sanny Nonyane; Lonny Yarmus Journal: Chest Date: 2015-09 Impact factor: 9.410
Authors: Helen E Davies; Eleanor K Mishra; Brennan C Kahan; John M Wrightson; Andrew E Stanton; Anur Guhan; Christopher W H Davies; Jamal Grayez; Richard Harrison; Anjani Prasad; Nicola Crosthwaite; Y C Gary Lee; Robert J O Davies; Robert F Miller; Najib M Rahman Journal: JAMA Date: 2012-06-13 Impact factor: 56.272
Authors: Edward T H Fysh; Alain Tremblay; David Feller-Kopman; Eleanor K Mishra; Mark Slade; Luke Garske; Amelia O Clive; Carla Lamb; Rogier Boshuizen; Benjamin J Ng; Andrew W Rosenstengel; Lonny Yarmus; Najib M Rahman; Nick A Maskell; Y C Gary Lee Journal: Chest Date: 2013-11 Impact factor: 9.410
Authors: Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies Journal: N Engl J Med Date: 2011-08-11 Impact factor: 91.245
Authors: Najib M Rahman; Justin Pepperell; Sunita Rehal; Tarek Saba; Augustine Tang; Nabeel Ali; Alex West; Gihan Hettiarachchi; Dipak Mukherjee; Johnson Samuel; Andrew Bentley; Lee Dowson; Jonathan Miles; C Frank Ryan; Ken Y Yoneda; Anoop Chauhan; John P Corcoran; Ioannis Psallidas; John M Wrightson; Rob Hallifax; Helen E Davies; Y C Gary Lee; Melissa Dobson; Emma L Hedley; Douglas Seaton; Nicky Russell; Margaret Chapman; Bethan M McFadyen; Rachel A Shaw; Robert J O Davies; Nick A Maskell; Andrew J Nunn; Robert F Miller Journal: JAMA Date: 2015 Dec 22-29 Impact factor: 56.272
Authors: Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith Journal: Updates Surg Date: 2017-08-31